NGF Blog

News

AVROBIO Receives Orphan-Drug Designation from FDA for AVR‑RD‑02

AVROBIO announced that the U.S. Food and Drug Administration (FDA)... Read more

Blog / About Gaucher Disease

Developing Enzyme Replacement Therapy – An Insider’s Perspective

Enzyme replacement therapy (ERT) was first approved for use by... Read more

Blog / About Gaucher Disease

[MEDTalks Video] Managing Bone Health

Growth in Gaucher: Managing Bone Health Dr. Heather A. Lau,... Read more

Blog / About Gaucher Disease

[MEDTalks Video] Does the Key Biomarker of Gaucher Disease Hold the Key to Understanding?

Illuminating Lyso-Gyl 1: Does the Key Biomarker of Gaucher Disease... Read more

Blog / About Gaucher Disease

Clinical Trials & Gaucher Disease: Phases, Types, & What You Should Know

Medical research has always been important for furthering our understanding... Read more

Blog / Insurance

Repealing the Affordable Care Act

 How Repealing the ACA Could Impact the Gaucher Disease... Read more

Blog / About Gaucher Disease

What You Should Know About At-Home Genetic and Ancestry Testing Kits

Genetic testing, including ancestry testing, has increased in popularity in... Read more

Blog / About Gaucher Disease

Gaucher: SRT, ERT & Drug Interactions | National Gaucher Foundation

Gaucher Disease: Enzyme Replacement Therapy, Substrate Reduction Therapy & Potential... Read more

Blog / About Gaucher Disease

Ambassador Spotlight: Lauren Edwards

What were the events leading up to your diagnosis? What... Read more

News

Prevail Therapeutics Announces Investigational New Drug Trial for Parkinson’s Disease

U.S. Food and Drug Administration (FDA) has accepted Prevail’s Investigational... Read more

Living a Better Today

Skip to content